webinar register page

A Clinical Update on Novavax’s Covid-19 Vaccine
Novavax’s Senior Vice President of Medical Affairs, Dr. Seth Toback, will provide a description of the technology used on the Novavax Covid-19 vaccine and discuss Novavax’s clinical development plan. The presentation will cover how a recombinant protein-based vaccine is different from other vaccine technologies and review the safety and efficacy profile of the Novavax vaccine. At the conclusion of the presentation, there will be a Q&A opportunity. Please note this webinar will not be recorded, however, presentation slides will be shared.

Sep 29, 2022 03:00 PM in Eastern Time (US and Canada)

* Required information